Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CTLA4 overexpression
i
Other names:
CTLA4, Cytotoxic T-Lymphocyte Associated Protein 4, Insulin-Dependent Diabetes Mellitus 12, Cytotoxic T-Lymphocyte Protein 4, Celiac Disease 3, CTLA-4, CD152, Ligand And Transmembrane Spliced Cytotoxic T Lymphocyte Associated Antigen 4, Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Form, Cytotoxic T-Lymphocyte-Associated Serine Esterase-4, Cytotoxic T-Lymphocyte-Associated Antigen 4, CD152 Isoform, CD152 Antigen, CELIAC3, IDDM12, ALPS5, GRD4
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1493
Related biomarkers:
Expression
Mutation
Others
‹
CTLA4 promoter hypomethylation (2)
CTLA4 promoter hypomethylation (2)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CTLA4 overexpression
Soft Tissue Sarcoma
CTLA4 overexpression
Soft Tissue Sarcoma
trabectedin
Sensitive: C3 – Early Trials
trabectedin
Sensitive
:
C3
trabectedin
Sensitive: C3 – Early Trials
trabectedin
Sensitive
:
C3
CTLA4 overexpression
Mantle Cell Lymphoma
CTLA4 overexpression
Mantle Cell Lymphoma
ibrutinib + rituximab
Sensitive: C3 – Early Trials
ibrutinib + rituximab
Sensitive
:
C3
ibrutinib + rituximab
Sensitive: C3 – Early Trials
ibrutinib + rituximab
Sensitive
:
C3
CTLA4 overexpression
Triple Negative Breast Cancer
CTLA4 overexpression
Triple Negative Breast Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
CTLA4 overexpression
Triple Negative Breast Cancer
CTLA4 overexpression
Triple Negative Breast Cancer
carboplatin + docetaxel
Sensitive: C3 – Early Trials
carboplatin + docetaxel
Sensitive
:
C3
carboplatin + docetaxel
Sensitive: C3 – Early Trials
carboplatin + docetaxel
Sensitive
:
C3
CTLA4 overexpression
Melanoma
CTLA4 overexpression
Melanoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
CTLA4 overexpression
Non Small Cell Lung Cancer
CTLA4 overexpression
Non Small Cell Lung Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.